Welcome to the e-CCO Library!

P106: Bifidobacterium longum subsp. longum microbiota-secreted bioactive peptide as a novel immunomodulatory compound in the human gastrointestinal tract
Year: 2018
Source: ECCO '18 Vienna
Authors:

S. Fernández Tomé1,2,3*, A. Montalbán-Arqués1,2,3, A. Díaz-Guerra1,2,3, J.M. Galván Román2,4, A.C. Marín1,2,3, I. Mora-Gutiérrez1,2,3, C. Santander1,2,3,5, B. Sánchez6, M. Chaparro1,2,3,5, J.P. Gisbert1,2,3,5, D. Bernardo1,2,3

Created: Thursday, 21 February 2019, 9:14 AM
P106: Binding properties of human TLR-9 receptor to cobitolimod – a candidate for treatment of active ulcerative colitis in late stage of clinical development
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Zargari A., Admyre C., Knittel T.

Created: Wednesday, 20 February 2019, 10:36 AM
P106: Cromoendoscopy versus second generation Narrow band Imaging for dysplasia detection in IBD. An interim analysis of a prospective randomized control trial.
Year: 2021
Source: ECCO'21 Virtual
Authors: Martin Arranz, E.(1);Suarez Ferrer, C.(1);García Ramirez, L.(2);Sanchez Azofra, M.(1);Rueda García, J.L.(1);Poza Cordón, J.(1);Martín Arranz, M.D.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P106: Identification of urine and serum diagnostic biomarkers of inflammatory bowel disease using a proteomic approach
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Baldan-Martin, M.(1)*;Azkargorta, M.(2);Lloro, I.(2);Soleto Fernández, I.(1);Orejudo, M.(1);Ramírez, C.(1);García, S.(1);Mercado, J.(1);Riestra, S.(3);Rivero, M.(4);Gutiérrez, A.(5);Rodríguez-Lago, I.(6);Fernández-Salazar, L.(7);Ceballos, D.(8);Benítez, J.M.(9);Aguas, M.(10);Bastón-Rey, I.(11);Bermejo, F.(12);Casanova, M.J.(1);Lorente, R.(13);Ber, Y.(14);Royo, V.(15);Esteve, M.(16);Elortza, F.(2);Gisbert, J.P.(1);Chaparro, M.(1);
Created: Friday, 14 July 2023, 10:48 AM
P106: Macrophages as a source of NOTCH Ligands in Crohn's disease: implications in fibrosis
Year: 2022
Source: ECCO'22
Authors: Edo, M.M.(1);Macias-Ceja, D.C.(2);Bauset, C.(2);Lis, L.(2);Coll, S.(2);Seco-Cervera, M.(3);Cosin-Roger, J.(3);Calatayud, S.(2);Barrachina, M.D.(2);Ortiz-Masiá, D.(1);
Created: Friday, 11 February 2022, 3:52 PM
P106: Maintenance treatment with granulocyte/monocyte adsorption in patients with inflammatory bowel disease and an initial response to treatment: a Swedish long-term prospective registry study
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

A. Lindberg1, 2, S. Lindgren3, M. Lördal4, S. Nilsson5, H. Svensson6, P. Karlen*1

Created: Friday, 22 February 2019, 9:49 AM
P106: Successful outcome of the transitional process of inflammatory bowel disease from paediatric to adult age: a 5-year experience
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

A. Testa1, O. M. Nardone*1, E. Giannetti2, A. Rispo1, M. Rea1, E. Scarpato2, A. Opramolla1, N. Imperatore1, I. Di Luna1, A. M. Staiano2, F. Castiglione1

Created: Friday, 22 February 2019, 9:41 AM
P107 The expression and regulation of Oncostatin M and its receptor in intestinal inflammation
Year: 2020
Source:

ECCO'20 Vienna

Authors:

R. Cineus1,2, D. Boesel1,2, S. Hainbuch1,2, C. Jukes1,2, Y.H. Hsieh1,2, J. Reich1,2, Z. Borek1,2, A. Kuehl1,3, A.N. Hegazy PhD, MD1,2

Created: Thursday, 30 January 2020, 10:12 AM
P107: Decreased epithelial keratinization contributes to defective wound healing in Crohn's disease fistula
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Beckerdrs., M.(1)*;Koelink, P.(1);Bemelman, W.(2);D'Haens, G.(3);Buskens, C.(2);Wildenberg, M.(1);
Created: Friday, 14 July 2023, 10:48 AM
P107: IL-34 and IL-36 family expressing cytotoxic T-cells and plasmacytoid dendritic cells are increased 
in patients with active inflammatory bowel disease
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

G. Fonseca Camarillo*1, E. Iturriaga Goyon2, J. Furuzawa Carballeda3, J. Yamamoto Furusho2

Created: Friday, 22 February 2019, 9:49 AM
P107: IL10 secretion endows intestinal human iNKT cells with regulatory functions towards pathogenic T lymphocytes in Crohn's disease patients
Year: 2022
Source: ECCO'22
Authors: Burrello, C.(1);Strati, F.(1);Diaz-Basabe, A.(1);Lattanzi, G.(1);Lopez, G.(2);Trombetta, E.(3);Conforti, F.S.(4);Botti, F.(5);Vecchi, M.(4);Fantini, M.C.(6);Caprioli, F.(4);Facciotti, F.(1);
Created: Friday, 11 February 2022, 3:52 PM
P107: Lactobacillus plantarum 06CC2 induces intestinal IL-10–producing dendritic cells to ameliorate acute experimental colitis in mice
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Tanaka A.*1,2, Kanmura S.1, Arima S.1, Sasaki F.1, Nasu Y.1, Tanoue S.1, Hashimoto S.1, Setoyama H.1, Ido A.1

Created: Wednesday, 20 February 2019, 10:36 AM
P107: MicroRNA signatures can differentiate the inflamed colonic mucosa from non-inflamed mucosa in ulcerative colitis patients
Year: 2018
Source: ECCO '18 Vienna
Authors:

S. Valmiki1*, V. Ahuja2, J. Paul1, R. Ranjha1, R. Ranjha1

Created: Thursday, 21 February 2019, 9:14 AM
P107: Monitoring inflammatory bowel disease in clinical practice using gut microbial markers in faecal samples. Prospective study in a clinical cohort.
Year: 2021
Source: ECCO'21 Virtual
Authors: Miquel Cusachs, J.O.(1);Bahí Saavedra, A.(2);Vila Currius, M.(3);Lliròs Dupre, M.(2);Leal Validivieso, C.(4);Aldeguer Manté, X.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P107: Value of faecal biomarkers are affected by extension of inflammation in ulcerative colitis
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

N. Nemoto*1, A. Sakuraba2, R. Ozaki2, T. Sato2, S. Tokunaga2, O. Kikuchi2, S. Minowa2, O. Ikezaki2, T. Mitsui2, M. Miura2, D. Saito2, M. Hayashida2, M. Yoneyama3, H. Mori2, H. Ohnishi4, T. Hisamatsu2

Created: Friday, 22 February 2019, 9:41 AM
P108 The importance of developing consensus-driven clinical data standards for Crohn’s disease to amplify data
Year: 2020
Source:

ECCO'20 Vienna

Authors:

J. Owen, R. Baker

Created: Thursday, 30 January 2020, 10:12 AM
P108: Cytokine levels differ during pregnancy amongst women with ulcerative colitis and Crohn’s disease
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

V. W. Huang*1, N. Hotte2, L. Ambrosio1, K. Smith2, J. Bal1, R. Foshaug1, K. I. Kroeker1, B. Halloran1, L. Dieleman1, R. N. Fedorak1, K. Madsen2

Created: Friday, 22 February 2019, 9:49 AM
P108: Development and evaluation of the i-Tracker Risankizumab and i-Tracker Anti-Risankizumab kits: rapid and innovative tests intended for monitoring patients treated with Risankizumab.
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Khater, G.(1)*;Noguier, G.(2);Daviere, S.(1);Montaillier, C.(2);Guilbert, V.(2);
Created: Friday, 14 July 2023, 10:48 AM
P108: Differential expression in colitis-associated cancer compared with Crohn’s disease and ulcerative colitis
Year: 2018
Source: ECCO '18 Vienna
Authors:

M. Sehn1, S. Elezkurtaj2, D. Cardoso da Silva3, B. Siegmund4, M. Kreis1, C. Holmer1, M. Hummel5, J. Gröne6, M. Schumann3*

Created: Thursday, 21 February 2019, 9:14 AM
P108: has been withdrawn
Year: 2021
Source: ECCO'21 Virtual
Created: Wednesday, 2 June 2021, 4:12 PM